Seattle Cancer Care Alliance
Latest from Seattle Cancer Care Alliance
Pembrolizumab Plus Sacituzumab Govitecan Yields Encouraging Antitumor Activity in Metastatic Urothelial Cancer
February 22, 2022
Article
Adding sacituzumab govitecan to second-line pembrolizumab garnered promising antitumor activity among patients with checkpoint inhibitor–naïve metastatic urothelial cancer.
Setting Boundaries Can Be a Challenge for Nurse Navigators
February 03, 2022
Video
Janelle Wagner, RN, OCN, Senior Manager of Patient Navigation Program for Community Sites, highlights some challenges commonly associated with nurse navigation, and how nurses can overcome them.
Confidence Is Key in Oncology Nurse Navigation
January 25, 2022
Video
An expert from Seattle Cancer Care Alliance highlights key skills in nurse navigation.
What Makes an Effective Nurse Navigator?
January 19, 2022
Article
Janelle Wagner, RN, OCN, Senior Manager of Patient Navigation Program for Community Sites, discusses the challenges and rewards of nurse navigation in oncology.
New Toxicity Grading Criteria Help Standardize Management of CAR T-Cell Therapy-Related AEs
August 31, 2021
Article
Newly standardized grading criteria will help to regulate the management of CAR T-cell therapy¬–related toxicities, like cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS).